Home > Boards > US Listed > Biotechs > Cel-Sci (CVM)

I’ll be the first in line for a

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
learning curve Member Profile
 
Followed By 35
Posts 7,823
Boards Moderated 0
Alias Born 02/15/12
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 7/7/2021 3:25:29 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/7/2021 10:51:52 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/7/2021 10:49:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/7/2021 10:45:24 AM
CEL-SCI says analysis of successful study arm was pre-specified in protocol Seeking Alpha - 7/7/2021 9:48:00 AM
CEL-SCI Corporation Issues Letter to Shareholders Business Wire - 7/7/2021 8:00:00 AM
CEL-SCI extends gains despite discussion on cancer trial Seeking Alpha - 7/2/2021 11:53:24 AM
Discussion of Results of CEL-SCI’s Phase 3 Trial Is Now Available Business Wire - 7/2/2021 11:20:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/2/2021 6:01:17 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2021 9:13:04 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2021 9:06:14 AM
Ocuphire Pharma, Predictive Oncology leads healthcare gainers; Altimmune, electroCore among major losers Seeking Alpha - 6/30/2021 11:03:36 AM
CEL-SCI to further discuss late-stage Multikine data in head and neck cancer Seeking Alpha - 6/30/2021 10:59:10 AM
CEL-SCI to Conduct Investor Call Regarding Phase 3 Results Following Annual Shareholder Meeting on July 1, 2021 Business Wire - 6/30/2021 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/29/2021 10:55:13 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/29/2021 8:30:14 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/28/2021 4:35:17 PM
CEL-SCI plummets 43% after phase 3 immunotherapy data misses primary endpoint Seeking Alpha - 6/28/2021 11:43:58 AM
CEL-SCI’s Multikine® Immunotherapy Produces Significant 14.1% 5-Year Survival Benefit (62.7% Vs 48.6%) in the Group Receiv... Business Wire - 6/28/2021 9:20:00 AM
CEL-SCI Corporation Invites Participants to Pre-Submit Questions for Annual Shareholder Meeting Business Wire - 6/25/2021 8:30:00 AM
CEL-SCI Announces the Closing of $31.7 Million Bought Deal Offering Business Wire - 6/11/2021 11:49:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/9/2021 4:09:46 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/9/2021 4:08:50 PM
CEL-SCI down 11% on $31.7M capital raise Seeking Alpha - 6/9/2021 3:56:17 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/9/2021 6:05:04 AM
learning curve   Friday, 02/28/20 02:30:14 AM
Re: fung_derf post# 29321
Post # of 40211 
I’ll be the first in line for a lawsuit if need be against geert. However, he has been a consistent character...so ....your comment regarding penny stock “letter” are absolutely irrelevant. I mean irrelevant!

One could come up with infinite conspiracies...
Then there is logic.

My guess is pre- arranged trade,coupled with demand resulted in excess public demand....
One could say such hypoihesies wouldn’t destroy value if demand was great. True. But! Based on assumptions... not comprehensive insight.

Just as the same I bought some much “gold type” investments...the demand is so excessive that the market is out of place and only taking buys, nobody is selling!
The same here at cvm.... buying is excessive....one could wait....or play volatility of wait.

Note: buying was overbearing today. I made no move other then small buy sub 11 that I consider irrelevant.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences